Vetsina has utilised the UK government’s Kickstart Scheme to partially fund the appointment of a new Laboratory Scientist, Brandon Shek, to help its team in developing innovative animal health diagnostics for veterinary use. “Brandon has an honours degree in Biotechnology from the University of Edinburgh and undertook a year-long master’s research project in Clinical Veterinary…
Vetsina Animal Diagnostics is seeking up to £3 million from investment partners to commercialise its microRNA-based diagnostic tests for the animal health market. Vetsina, formed last year as a joint venture between Roslin Technologies and Destina Genomics, and initially focused on detecting microRNA biomarkers for infections, illnesses and disease in animals. It is on target to launch…
Vetsina Animal Diagnostics – the new company formed by Roslin Technologies and Destina Genomics – is excited to announce its expansion with the appointment of a new Laboratory Scientist, and a new Head of Research. Laboratory Scientist, Dr. Baltasar Lucendo Villarin, has extensive experience in hepatocyte biology after studying the effect of maternal smoking in…
Professor Jacqueline Matthews, Chief Technology Officer, Roslin Technologies Limited has joined the board at Vetsina Animal Diagnostics Ltd as a non-executive director. She replaces Glen Illing who has stepped down. Vetsina CEO, Dr. Simon Wheeler, said: “We are grateful to Glen Illing for his support while we established Vetsina and thank him for his contributions…
Vetsina Animal Diagnostics – the new company formed by Roslin Technologies and DESTINA Genomics – has announced the appointment of David Whitcombe as Non-Executive Director. David has more than 10 years of academic research and 15 years in industrial R&D. During his career, he has produced several publications and patents, including the Scorpions technology that…
Vetsina Animal Diagnostics has appointed former Global Head of Research and Development with Novartis Animal Health, Dr. Peter Wells as its first Chairman. Dr. Wells has extensive experience in the animal health pharmaceutical industry having held senior positions in major global companies for almost 30 years. Mainly involved in directing the research and development of…
Vetsina Animal Diagnostics – the new company formed by Roslin Technologies and DESTINA Genomics – has announced the appointment of Dr. Simon Wheeler as its first Chief Executive Officer (CEO). Dr. Wheeler is a veterinarian and strategic leader with over 20 years’ experience of the global animal health industry. He has previously held strategic, technical,…
Roslin Technologies and DESTINA Genomics have joined forces to launch a new company which will offer significant developments in animal treatment and care. In particular, the new venture, Vetsina Animal Diagnostics, will create solutions around the speed of testing, ability to detect low concentrations of biomarkers, utility of existing laboratory equipment, and the ability to…
Vetsina Animal Diagnostics has been established to maximise the impact of a revolutionary chemical-based system for detecting nucleic acids and single nucleotide polymorphisms, for the development of simple, fast, accurate & cost-effective products for PCR-free detection of microRNAs in human medicine, by applying it to animal health.
Vetsina will also research the animal diagnostics arena to focus on targets based on market need, technical feasibility and the development of a balanced portfolio.
It was founded by Roslin Technologies and Destina Genomics.
